Century Textiles & Industries Ltd. - Research Center
500040 CENTURYTEX Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 23 | Mar' 23 | Dec' 22 | Sep' 22 | Jun' 22 | |
|---|---|---|---|---|---|
| Sales | 1,117.14 | 1,208.01 | 1,168.20 | 1,231.19 | 1,187.81 |
| Operating profit | 161.44 | 159.59 | 117.54 | 208.18 | 160.59 |
| Interest | 38.91 | 24.15 | 23.35 | 22.93 | 18.76 |
| Gross profit | 157.66 | 156.03 | 108.00 | 201.93 | 152.29 |
| EPS (Rs) | 2.12 | 15.83 | 2.91 | 8.59 | 5.65 |
Quarterly
results in details
| Jun' 23 | Mar' 23 | Dec' 22 | Sep' 22 | Jun' 22 | |
|---|---|---|---|---|---|
| Other income | 35.13 | 20.59 | 13.81 | 16.68 | 10.46 |
| Stock adjustment | -14.72 | 20.37 | -45.64 | 0.32 | -35.99 |
| Raw material | 647.84 | 675.31 | 709.85 | 652.30 | 693.91 |
| Power and fuel | - | 133.72 | 166.24 | 191.92 | 188.73 |
| Employee expenses | 64.40 | 64.70 | 69.80 | 67.67 | 64.45 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 258.18 | 154.32 | 150.41 | 110.80 | 116.12 |
| Provisions made | - | - | - | - | - |
| Depreciation | 56.75 | 55.70 | 55.94 | 55.91 | 55.25 |
| Taxation | 12.81 | 57.74 | 19.54 | 50.12 | 33.95 |
| Net profit / loss | 23.70 | 176.80 | 32.52 | 95.90 | 63.09 |
| Extra ordinary item | -64.40 | 134.21 | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 111.69 | 111.69 | 111.69 | 111.69 | 111.69 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 14.45 | 13.21 | 10.06 | 16.91 | 13.52 |
| GPM (%) | 13.68 | 12.70 | 9.14 | 16.18 | 12.71 |
| NPM (%) | 2.06 | 14.39 | 2.75 | 7.69 | 5.27 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis